Braunwald E: Mechanism of action of calcium-channel blocking agents . N Engl J Med 1982;;307:1618-1627.
Aoki K, Kondo S, Mochizuki A, et al: Antihypertensive effect of cardiovascular Ca++ antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade . Am Heart J 1978;;96:218-226.
Lederballe Pederson O, Mikkelsen E: Acute and chronic effects of nifedipine in arterial hypertension . Eur J Clin Pharmacol 1978;;14:375-381.
Kambara H, Fujimoto K, Wakabayashi A, et al: Primary pulmonary hypertension: Beneficial therapy with diltiazem . Am Heart J 1981;;101: 230-231.
Stone PH, Muller JE: Nifedipine therapy for recurrent ischemic pain following myocardial infarction . Clin Cardiol 1982;;5:223-230.
Deanfield J, Wright C, Fox K: Treatment of angina pectoris with nifedipine: Importance of dose titration . Br Med J 1983;;286:1467-1471.
Matsumoto S, Ito T, Sada T, et al: Hemodynamic effects of nifedipine in congestive heart failure . Am J Cardiol 1980;;46:476-480.
Klugmann S, Salvi A, Camerini F: Haemodynamic effects of nifedipine in heart failure . Br Heart J 1980;;43:440-446.
Lorell BH, Paulus WJ, Grossman W, et al: Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy . Circulation 1982;; 65:499-507.
Rodeheffer RJ, Rommer JA, Wigley F, et al: Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon . N Engl J Med 1983;;308:880-883.
Bertel O, Conen D, Radu EW, et al: Nifedipine in hypertensive emergencies . Br Med J 1983;;286:19-21.
Guazzi M, Olivari MT, Polese A, et al: Nifedipine a new antihypertensive with rapid action . Clin Pharmacol Ther 1977;;22:528-532.
Beer H, Callegas I, Cohen A, et al: Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension . Chest 1981;;79: 571-574.
Husted SE, Kreammer Nielsen H, Christensen CK, et al: Long term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoreceptor blocking agent . Eur J Clin Pharmacol 1982;;22:101-103.
Ganong WF: Review of Medical Physiology , Los Altos, Calif, Lange Medical Publications, 1981;, pp 43-59.
Kohlhardt M, Bauer B, Krause H, et al: New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres: Studies with the voltage clamp technique . Experientia 1972;;28:288-289.
Braunwald E: Calcium channel blockers: Pharmacologic considerations . Am Heart J 1982;; 104:665-671.
Rowland E, Evans T, Krikler D: Effect of nifedipine on atrioventricular conduction as compared with verapamil: Intracardiac electrophysiological study . Br Heart J 1979;;42:124-127.
Horster FA: Pharmacokinetics of nifedipine-14C in man , in Hashimoto K, Kimura E, Kobayashi T (eds): First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 67-70.
Braasch W, Ebner F: Long-term treatment with nifedipine , in Hashimoto K, Kimura E, Kobayashi T, eds: First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 200-204.
Hayase S, Hirakawa S, Hosokawa S, et al: Therapeutic efficacy: Clinical and basic hemodynamic studies on nifedipine , in Hashimoto K, Kimura E, Kobayashi T (eds): First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 77-83.
Bertel O, Buhler FR, Kiowski W, et al: Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure and plasma catecholamines in patients with essential hypertension . Hypertension 1980;;2:130-138.